Target intelligence / Profile preview

BRI3 binding protein pseudogene 1 (BRI3BPP1)

Target: BRI3BPP1
Molecular classification: Other (Pseudogene)

Overview

BRI3 binding protein pseudogene 1 (BRI3BPP1) is a non-coding pseudogene and does not produce a functional protein or have known biological activity. It is not considered a therapeutic target, nor does it play a recognized role in disease or pharmacology. Related functional and disease-relevant information pertains to the protein-coding gene BRI3 binding protein (BRI3BP), not the pseudogene itself[3]. BRI3BPP1 should not be listed as a molecular target. Therapeutic, mechanistic, and clinical details available in the literature refer to BRI3BP (BRI3 binding protein); the pseudogene BRI3BPP1 is only a genomic sequence without known translation or direct biological function[3].

Other names: BRI3BPP1

Beyond the preview

Go deeper on BRI3 binding protein pseudogene 1 (BRI3BPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BRI3 binding protein pseudogene 1 (BRI3BPP1).

Explore the full profile